跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 138 条关于
“SAMHSA”
全部
138
临床试验
110
药物
8
机构
6
资讯
14
2个月前
SAMHSA Unveils $281 Million in MOUD Grants While Restricting Harm Reduction and Mandating Psychosocial Services
去年
Federal Agencies Highlight Efforts to Advance PTSD Treatments, Including Psychedelics
11个月前
PleoPharma Raises $36M Series B to Advance First-in-Class Cannabis Withdrawal Treatment to Phase 3
去年
FDA Fast-Tracks Novel Drug PP-01 for Cannabis Withdrawal Syndrome Treatment
上个月
Federal Survey Reveals Declining Substance Use and Improved Mental Health Among U.S. Youth
3个月前
The Rise of AI 'Para-therapy': Nearly One in Five Young Adults Now Use Chatbots for Mental Health, Raising Clinical and Regulatory Concerns
前天
FDA Convenes Landmark Public Hearing on Psychedelic Therapeutics as Agency Finalizes Regulatory Framework
3个月前
Royalty Pharma to Present at Goldman Sachs 47th Annual Global Healthcare Conference
去年
Neurocrine Biosciences' Crenessity Receives FDA Approval for Congenital Adrenal Hyperplasia
去年
Goldman Sachs Downgrades Dynavax on Competitive Pressures in Shingles and Hepatitis B Markets
第 1 页,共 2 页
上一页
下一页